How to manage waldenstr öm’s macroglobulinemia in 2024

Waldenstr öm’s Macroglobulinemia (WM) belongs to the group of indolent B-cell lymphomas. It is seen as a clinicopathological entity characterized by the infiltration of the bone marrow by lymphoplasmacytic lymphoma, and the presence of monoclonal IgM paraprotein in the serum [1,2]. By this, this lymphoma c auses symptoms due to lymphoma infiltration, such as anemia or lymph node enlargement, well known from other nodal B-cell lymphomas e.g. follicular lymphoma, as well as symptoms due to the IgM protein causing symptoms such as neuropathy, hemolysis or hyperviscosity [3].
Source: Cancer Treatment Reviews - Category: Cancer & Oncology Authors: Tags: Tumour Review Source Type: research